Annual Secretarial Compliance Report for the year ended March 31, 2025.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camlin Fine Sciences Ltd has submitted its Annual Secretarial Compliance Report to BSE and NSE, as required under SEBI Listing Regulations. The report, prepared by JHR & Associates (Practising Company Secretaries), confirms that the company was in full compliance with SEBI regulations, the Companies Act, and applicable secretarial standards for FY25. No deviations, violations, or penalties were reported during the review period. All key affirmations are in order, including timely website disclosures, no disqualification of directors, proper prior approvals for related party transactions, compliance with insider trading norms, and no action taken by SEBI or stock exchanges against the company. Performance evaluation of the board and independent directors was carried out in the first quarter of FY25. Buyback regulations and non-convertible securities rules were noted as not applicable during the year.
This is a routine regulatory filing with a clean compliance record, indicating good corporate governance standards. No negative signals for shareholders; this is a neutral, procedural disclosure that should not affect stock price.